Anebulo Pharmaceuticals GAAP EPS of -$0.05
Source: SeekingAlpha
2026-02-12 16:49:20 ET
More on Anebulo Pharmaceuticals
- Seeking Alpha’s Quant Rating on Anebulo Pharmaceuticals
- Financial information for Anebulo Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Anebulo Pharmaceuticals GAAP EPS of -$0.05
Anebulo Pharmaceuticals Inc.
NASDAQ: ANEB
ANEB Trading
11.89% G/L:
$0.5034 Last:
66,601 Volume:
$0.4397 Open:
ANEB Latest News
February 12, 2026 04:15:00 pm
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
February 06, 2026 09:00:00 am
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC
ANEB Stock Data
$19,433,078
3,615,456
1.14%
7
N/A
Biotechnology & Life Sciences
Healthcare
US
Lakeway
